Kusajili – Clinical trials directory

Result of your search per sponsor: Pierre Fabre Médicament/Institut de Recherche Pierre Fabre

Woman and Man Max 99 years
Pierre Fabre Médicament/Institut de Recherche Pierre Fabre Update Il y a 4 ans

Bronchodilator properties and safety of a repeated dose of V0162 inhalation powder in asthma To assess the bronchodilator properties of V0162 inhalation powder delivered once daily during 8 days in adult patients with asthma usually treated with ICS and LABA.

Country None
organs None
Specialty None

Closed trial

More information